| 04:03p | Sector Update: Health Care Stocks' Losses Gain Speed Near Monday Close | MT |
| 03:44p | Sector Update: Health Care | MT |
| 02:30p | Johnson & Johnson Worst Performer in the DJIA So Far Today -- Data Talk | DJ |
| 02:11p | Top Midday Decliners | MT |
| 01:20p | Mega-Cap Tech Earnings on Tap; Fed's Policy Leanings Cool US Equity Investors' Risk App.. | MT |
| 01:02p | Drugmakers prevail in dispute over U.S. discount drug program | RE |
| 12:25p | AstraZeneca Doses First Patient in Phase 3 Study of Datopotamab Deruxtecan to Treat Lun.. | MT |
| 12:03p | Johnson & Johnson's Bankruptcy Petition for Talc Unit Dismissed by Court; Shares Down M.. | MT |
| 11:59a | Johnson & Johnson Stock Falls Amid Reports US Appeals Court Rejected Company's Use of B.. | MT |
| 11:41a | Johnson & Johnson Talc Bankruptcy Case Thrown Out b.. | MT |
| 11:36a | Daiichi begins Tropion-Lung07 phase 3 trial for lung cancer treatment | AN |
| 11:06a | European Equities Start the Week Modestly Higher Amid German GDP Contraction | MT |
| 08:01a | Berenberg Bank Adjusts Merck & Company Price Target to $125 From $115, Maintains Buy Ra.. | MT |
| 07:53a | Berenberg Lowers Price Target on Roche, Maintains Buy Recommendation | MT |
| 06:59a | ROCHE HOLDINGS AG : Berenberg reiterates its Buy rating | MD |
| 01/27 | Eli Lilly's Oncology Unit Gets US FDA's Approval for Mantle Cell Lymphoma Drug | MT |
| 01/27 | FDA Approves Eli Lilly's Jaypirca to Treat Lymphoma Patients | DJ |
| 01/27 | Eli Lilly Receives US FDA's Nod of Jaypirca to Treat Mantle Cell Lymphoma | MT |
| 01/27 | Eli Lilly and Company Announces That the U.S. Food and Drug Administration Approved Jay.. | CI |
| 01/27 | Johnson & Johnson's Janssen Says Carvykti Meets Target in Late-Stage Blood Cancer Trial | MT |
| 01/27 | Eli Lilly's Diabetes Drug Recommended for Approval by European Medicines Agency Committ.. | MT |
| 01/27 | Johnson & Johnson Unit Withdraws European Application for Imbruvica Drug Combination to.. | MT |
| 01/27 | Merck Says Keytruda Approved by FDA as Adjuvant Treatment for Non-Small Cell Lung Cance.. | MT |
| 01/27 | Merck Announces the U.S. Food and Drug Administration has Approved KEYTRUDA | CI |
| 01/26 | Merck & Co.'s Animal Health Unit Wins US FDA Nod for Expanded Use of Flea Drug for Dogs | MT |
| 01/26 | Sector Update: Healthcare Stocks Climb Back to Finish Higher | MT |
| 01/26 | Merck Animal Health Division Says US FDA Approves Expanded Indication of Bravecto Chews.. | MT |
| 01/26 | Eli Lilly Earmarks $1 Million to Boost Cold Chain Capacity in 17 Countries | MT |
| 01/26 | Sector Update: Health Care Stocks Advance Pre-Bell Thursday | MT |
| 01/26 | Evotec, Johnson & Johnson's Janssen Biotech Enter Cancer Drug Development Collaboration | MT |
| 01/26 | Evotec Shares Climb After Agreement With Janssen on Immunotherapies Development | DJ |
| 01/26 | Evotec Starts Oncology-development Collaboration With Johnson & Johnson Unit | MT |
| 01/26 | Roche Develops New COVID-19 PCR Test for Omicron Subvariant XBB.1.5 | MT |
| 01/26 | Roche launches new test to detect fast spreading Omicron sub-variant | RE |
| 01/26 | Roche Launches COVID-19 PCR Test to Detect the Fast Spreading XBB.1.5 Omicron Sub-Varia.. | CI |
| 01/25 | Merck & Co.'s Keytruda Combo Prolongs Survival in Late-stage Biliary Tract Cancer Study | MT |
| 01/25 | Morgan Stanley Adjusts Price Target on Johnson & Johnson to $180 From $176, Maintains E.. | MT |
| 01/25 | Roche, Sysnav to Develop Outcome Measurements for Movement Impairment Ailments | MT |
| 01/25 | NOVO NORDISK : Buy rating from JP Morgan | MD |
| 01/25 | Atlantic Equities Adjusts Johnson & Johnson's Price Target to $168 From $160, Keeps Neu.. | MT |
| 01/25 | Novo Nordisk Signs New License Agreement with Howwe Technologies | MT |
| 01/25 | Merck to Cease Phase 3 Trial for Treatment of Prostate Cancer Due to Failure in Meeting.. | MT |
| 01/25 | Merck Reports Keytruda Phase 3 Success, Failure | DJ |
| 01/25 | Merck Announces KEYNOTE-991 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus Enzalutamid.. | CI |
| 01/25 | Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy Significantly Improved Overall.. | CI |
| 01/25 | NOVO NORDISK : Receives a Buy rating from Goldman Sachs | MD |
| 01/25 | ROCHE HOLDINGS AG : Barclays reaffirms its Buy rating | MD |
| 01/25 | NOVO NORDISK : Barclays keeps its Buy rating | MD |
| 01/25 | Sysnav Healthcare Announces A Multi-Year Collaboration with Roche Based on Sysnav's Pro.. | CI |
| 01/25 | RLS Global Chairman to Depart in February; Successor Nominated | MT |
| 01/24 | Sector Update: Health Care Stocks Still Sagging Near Close | MT |
| 01/24 | Merck & Company Keeps Quarterly Dividend at $0.73 a Share; Payable April 10 to Holders .. | MT |
| 01/24 | Surprise Manufacturing Gain Leaves Equities Mixed | MT |
| 01/24 | Sector Update: Health Care Stocks Retreating on Tuesday | MT |
| 01/24 | Sector Update: Health Care | MT |
| 01/24 | Merck Announces Dividend for the Second-Quarter of 2023 , Payable on April 10, 2023 | CI |
| 01/24 | Technology Heavyweights Earnings Kick-Start, Unexpected Improvement in Manufacturing In.. | MT |
| 01/24 | Johnson & Johnson on Track for Longest Losing Streak Since August 1981 -- Data Talk | DJ |
| 01/24 | Johnson &Johnson CFO on Earnings Forecast, Costs, and Consumer Spinoff | MT |
| 01/24 | Global markets live: GE, J&J, Verizon, Lockheed Martin, Halliburton... | |
| 01/24 | Sector Update: Health Care Stocks Flat to Lower Pre-Bell Tuesday | MT |
| 01/24 | Prospect of Further Federal Reserve Interest Rate Increases Pressuring Exchange-Traded .. | MT |
| 01/24 | Johnson & Johnson Fourth-Quarter Revenue Falls on Lower COVID-19 Vaccine Sales; Guides .. | MT |
| 01/24 | Transcript : Johnson & Johnson, Q4 2022 Earnings Call, Jan 24, 2023 | CI |
| 01/24 | FTSE 100 down as UK PMIs raise recession fears | AN |
| 01/24 | Eli Lilly to Allocate Another $450 Million Toward Manufacturing Capacity Expansion at N.. | MT |
| 01/24 | Johnson & Johnson Q4 Adjusted Profit Rises; Sales Drop; Full-Year 2023 Guidance Release.. | MT |
| 01/24 | Eli Lilly Plans $450 Million Investment To Expand US Manufacturing Site | MT |
| 01/24 | Eli Lilly and Company Plans to Invest Additional $450 Million At Manufacturing Site in .. | CI |
| 01/24 | Earnings Flash (JNJ) JOHNSON & JOHNSON Reports Q4 Revenue $23.71B, vs. Street Est of $2.. | MT |
| 01/24 | Earnings Flash (JNJ) JOHNSON & JOHNSON Reports Q4 EPS $2.35, vs. Street Est of $2.24 | MT |
| 01/24 | Johnson & Johnson Reports Earnings Results for the Fourth Quarter Ended January 01, 202.. | CI |
| 01/24 | Johnson & Johnson Reports Earnings Results for the Full Year Ended January 01, 2023 | CI |
| 01/23 | Global markets live: Abbott, Goldman Sachs, Alphabet, Eli Lilly, Pay.. | |
| 01/23 | SVB Securities Adjusts Merck & Co.'s Price Target to $120 From $112, Keeps Outperform R.. | MT |
| 01/23 | Stocks Edge Down Pre-Bell Over Lack of Catalysts; Asia Strong, Europe Wobbles | MT |
| 01/23 | ROCHE HOLDINGS AG : Goldman Sachs remains its Buy rating | MD |
| 01/22 | Eli Lilly Seeks US FDA Nod for Expanded Use of Diabetes Pill Jardiance in Chronic Kidne.. | MT |
| 01/20 | S&P 500 Posts 0.7% Weekly Drop as Q4 Reports Add to Recession Fears; Industrials Lead D.. | MT |
| 01/20 | Eli Lilly & Co Announces FDA Decision Not to Grant Accelerated Approval to Donanemab fo.. | CI |
| 01/20 | Johnson & Johnson's 2023 Outlook to be in Focus, With Fourth-Quarter Results Seen Toppi.. | MT |
| 01/20 | Johnson & Johnson Q4 Results Likely to be In-Line With Outlook, BofA Says | MT |
| 01/20 | Eli Lilly's NDA for Jardiance to Treat Chronic Kidney Disease Accepted by FDA | MT |
| 01/20 | Sector Update: Health Care Stocks Mixed Premarket Friday | MT |
| 01/20 | US FDA Accepts Supplemental New Drug Application for Jardiance® for Adults with Chronic.. | CI |
| 01/20 | Sector Update: Health Care | MT |
| 01/20 | NOVO NORDISK : UBS reaffirms its Sell rating | MD |
| 01/20 | SVB Securities Adjusts Price Target on Johnson & Johnson to $186 From $194, Maintains O.. | MT |
| 01/20 | Eli Lilly Alzheimer's drug setback extends rival Biogen's lead - analysts | RE |
| 01/20 | ROCHE HOLDINGS AG : UBS remains Neutral | MD |
| 01/20 | Eli Lilly Says FDA Rejected Accelerated Approval for Alzheimer's Drug Due to Insufficie.. | MT |
| 01/19 | Eli Lilly Fails to Clinch Accelerated Approval for Alzheimer's Drug in US | MT |
| 01/19 | Eli Lilly and Company Announces U.S. Food and Drug Administration Issues Complete Respo.. | CI |
| 01/19 | Evaxion Biotech Says Cancer Immunotherapy Candidate EVX-01, With Keytruda, Gets US FDA .. | MT |
| 01/19 | ROCHE HOLDINGS AG : Buy rating from Goldman Sachs | MD |
| 01/19 | ROCHE HOLDINGS AG : JP Morgan remains a Sell rating | MD |
| 01/19 | ROCHE HOLDINGS AG : Downgraded to Sell by Deutsche Bank | MD |
| 01/19 | Roche's Liver Cancer Combo Extends Recurrence-free Survival In Late-stage Study | MT |
| 01/19 | Roche Announces the Phase III IMbrave050 Study Met Its Primary Endpoint of Recurrence-F.. | CI |
| 01/18 | Switzerland's Roche Signs Partnership in Hong Kong to Boost Life Science Innovation | MT |
Google
Twitter
Facebook
Apple
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
